Ankur Drugs and Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 14, 2012, inter alia, to transact the following agenda:
1. To approve the un-audited financial results of the Company for the Quarter Ended June 30, 2012.
2. To consider the Appointment of Mr. A. K. Khadke (representative of Central Bank of India) as Nominee Director on the Board of Directors of the Company.
NSE: ANKURDRUGS
Source: 
